Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progesterone from ovulatory menstrual cycles is an important cause of breast cancer
Herjan J.T. Coelingh Bennink, Iman J. Schultz, Marcus Schmidt, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Breastfeeding’s protective role in alleviating ovarian cancer burden: a comprehensive review
Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu
Annals of Medicine and Surgery (2024)
Open Access | Times Cited: 7
Rat Models of Hormone Receptor-Positive Breast Cancer
Raquel Nicotra, Catrin Lutz, Hendrik A. Messal, et al.
Journal of Mammary Gland Biology and Neoplasia (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 7
Risk factors for breast cancer subtypes by race and ethnicity: a scoping review
Amber N. Hurson, Thomas U. Ahearn, Hela Koka, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 12, pp. 1992-2002
Open Access | Times Cited: 6
Dual role of pregnancy in breast cancer risk
Shiting Fu, Ke Hao, Huozhong Yuan, et al.
General and Comparative Endocrinology (2024) Vol. 352, pp. 114501-114501
Closed Access | Times Cited: 4
Risk factors for breast cancer: Knowledge and prevention
Riya Sharma, Shanoo Sharma, Anu Dhiman, et al.
Elsevier eBooks (2025), pp. 11-27
Closed Access
Niosomes as a Targeted Drug Delivery system in the Treatment of Breast Cancer: Preparation, Classification, and Mechanisms of Cellular Uptake
Muneeb UrRahman, Hafiz Rashid Hussain, Huzaifa Akram, et al.
Journal of drug targeting (2025), pp. 1-36
Closed Access
Innovative approaches in breast cancer therapy: repurposing nanocarriers for enhanced outcomes
Sana Naaz Siddiqui, Md. Faheem Haider, M.A. Rahman
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Premature ovarian insufficiency and the risk of breast cancer: author reply
Nick Panay, Nathalie Vermeulen, Richard A. Anderson, et al.
Climacteric (2025), pp. 1-2
Closed Access
Premature ovarian insufficiency and the risk of breast cancer
Herjan J.T. Coelingh Bennink, Jan F M Egberts, Frank Z. Stanczyk
Climacteric (2025), pp. 1-2
Closed Access
Systemic hormone therapy after breast and gynecological cancers: an Italian expert group consensus opinion
Angelo Cagnacci, Paola Villa, G. Grassi, et al.
Climacteric (2024) Vol. 28, Iss. 1, pp. 4-14
Closed Access | Times Cited: 2
Impact of Cumulative Exposure to Circulating Ovarian Sex Hormones on Increasing the Risk of Hormone Receptor-Positive Breast Cancer
Swati Sucharita Mohanty, Sumit Subhadarshi Mohanty, Soumya Surath Panda, et al.
Journal of Bio-X Research (2024) Vol. 7
Open Access | Times Cited: 1
Transcriptomic Profile of Breast Tissue of Premenopausal Women Following Treatment with Progesterone Receptor Modulator: Secondary Outcomes of a Randomized Controlled Trial
Deborah Utjés, Nageswara Rao Boggavarapu, Mohammed Fatih Rasul, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7590-7590
Open Access | Times Cited: 1
Age-Stratified Assessment of the Impact of Breast Cancer Knowledge on the Lifestyle and Dietary Patterns Among Nigerian Females
Magdalene Eno Effiong, Israel Sunmola Afolabi, Shalom Nwodo Chinedu
JCO Global Oncology (2024), Iss. 10
Open Access | Times Cited: 1
Oncogenic BRCA1,2 Mutations in the Human Lineage—A By-Product of Sexual Selection?
Tatyana V. Korneenko, Nikolay B. Pestov
Biomedicines (2023) Vol. 12, Iss. 1, pp. 22-22
Open Access | Times Cited: 2
Lack of evidence that progesterone in ovulatory cycles causes breast cancer
Anne Gompel, Vanadin Seifert‐Klauss, James A. Simon, et al.
Climacteric (2023) Vol. 26, Iss. 6, pp. 634-637
Open Access | Times Cited: 1
Progesterone and not estrogens or androgens causes breast cancer
Herjan J.T. Coelingh Bennink, Frank Z. Stanczyk
Climacteric (2024) Vol. 27, Iss. 2, pp. 217-222
Closed Access
Transcriptomic profile of normal breast tissue post-mifepristone treatment: secondary outcomes of a randomized controlled trial
Deborah Utjés, Nageswara Rao Boggavarapu, Mohammed Fatih Rasul, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Risk factors for breast cancer subtypes by race and ethnicity: A scoping review of the literature
Amber N. Hurson, Thomas U. Ahearn, Hela Koka, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The Potential Health Risks and Benefits of Progesterone in the Transgender Woman Population—A Narrative Review
Simone Szymczyk, Katarzyna Mączka, Lidia Mądrzak, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6795-6795
Open Access
In-utero exposure to polybrominated biphenyl (PBB) and menstrual cycle function in adulthood
Suman Barat, Robert B. Hood, Metrecia L. Terrell, et al.
International Journal of Hygiene and Environmental Health (2023) Vol. 256, pp. 114297-114297
Closed Access
Page 1

Scroll to top